Artificial Intelligence in Diabetes Management Market Research Report by Device (Diagnostic Devices, Glucose Monitoring Devices, and Insulin Delivery Devices), by technique (Case-based Reasoning and Intelligent Data Analysis) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from USD 347.73 Million in 2020 to USD 1,275.42 Million by the end of 2025.
2. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from EUR 304.90 Million in 2020 to EUR 1,118.31 Million by the end of 2025.
3. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from GBP 271.05 Million in 2020 to GBP 994.18 Million by the end of 2025.
4. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from JPY 37,112.36 Million in 2020 to JPY 136,120.28 Million by the end of 2025.
5. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from AUD 504.96 Million in 2020 to AUD 1,852.08 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Artificial Intelligence in Diabetes Management to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Device, the Artificial Intelligence in Diabetes Management Market studied across Diagnostic Devices, Glucose Monitoring Devices, and Insulin Delivery Devices.
Based on technique, the Artificial Intelligence in Diabetes Management Market studied across Case-based Reasoning and Intelligent Data Analysis.
Based on Geography, the Artificial Intelligence in Diabetes Management Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence in Diabetes Management Market including Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, Diabnext, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann-La Roche Ltd, HCL Technologies Limited, IBM Corporation, Karger AG, Medtronic PLC, Nasdaq Inc, Novartis AG, Novo Nordisk A/S, Sanofi SA, Virta Health Corp., Vodafone Group PLC, Whisk, and xbird GmbH.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Diabetes Management Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Artificial Intelligence in Diabetes Management Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Diabetes Management Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Diabetes Management Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Diabetes Management Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Diabetes Management Market?
6. What are the modes and strategic moves considered suitable for entering the Global Artificial Intelligence in Diabetes Management Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from USD 347.73 Million in 2020 to USD 1,275.42 Million by the end of 2025.
2. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from EUR 304.90 Million in 2020 to EUR 1,118.31 Million by the end of 2025.
3. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from GBP 271.05 Million in 2020 to GBP 994.18 Million by the end of 2025.
4. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from JPY 37,112.36 Million in 2020 to JPY 136,120.28 Million by the end of 2025.
5. The Global Artificial Intelligence in Diabetes Management Market is expected to grow from AUD 504.96 Million in 2020 to AUD 1,852.08 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Artificial Intelligence in Diabetes Management to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Device, the Artificial Intelligence in Diabetes Management Market studied across Diagnostic Devices, Glucose Monitoring Devices, and Insulin Delivery Devices.
Based on technique, the Artificial Intelligence in Diabetes Management Market studied across Case-based Reasoning and Intelligent Data Analysis.
Based on Geography, the Artificial Intelligence in Diabetes Management Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence in Diabetes Management Market including Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, Diabnext, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann-La Roche Ltd, HCL Technologies Limited, IBM Corporation, Karger AG, Medtronic PLC, Nasdaq Inc, Novartis AG, Novo Nordisk A/S, Sanofi SA, Virta Health Corp., Vodafone Group PLC, Whisk, and xbird GmbH.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Diabetes Management Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Artificial Intelligence in Diabetes Management Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Diabetes Management Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Diabetes Management Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Diabetes Management Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Diabetes Management Market?
6. What are the modes and strategic moves considered suitable for entering the Global Artificial Intelligence in Diabetes Management Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. technique Outlook
3.4. Device Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for smart glucose monitoring device
5.1.1.2. Rising geriatric population and unhealthy lifestyle
5.1.1.3. Large number of type 2 diabetes patients
5.1.2. Restraints
5.1.2.1. Expensive AI-based medical devices
5.1.3. Opportunities
5.1.3.1. Increasing mobile apps to monitor and manage diabetes
5.1.3.2. Inclination towards the home care or self-management of diabetes
5.1.4. Challenges
5.1.4.1. Lack of awareness among the people
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY DEVICE
6.1. Introduction
6.2. Diagnostic Devices
6.3. Glucose Monitoring Devices
6.4. Insulin Delivery Devices
7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TECHNIQUE
7.1. Introduction
7.2. Case-based Reasoning
7.3. Intelligent Data Analysis
8. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Bigfoot Biomedical, Inc.
12.3. Cardinal Health Inc.
12.4. Crayon Group
12.5. Diabnext
12.6. DreaMed Diabetes, Ltd.
12.7. Eyenuk, Inc.
12.8. F. Hoffmann-La Roche Ltd
12.9. HCL Technologies Limited
12.10. IBM Corporation
12.11. Karger AG
12.12. Medtronic PLC
12.13. Nasdaq Inc
12.14. Novartis AG
12.15. Novo Nordisk A/S
12.16. Sanofi SA
12.17. Virta Health Corp.
12.18. Vodafone Group PLC
12.19. Whisk
12.20. xbird GmbH
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. technique Outlook
3.4. Device Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for smart glucose monitoring device
5.1.1.2. Rising geriatric population and unhealthy lifestyle
5.1.1.3. Large number of type 2 diabetes patients
5.1.2. Restraints
5.1.2.1. Expensive AI-based medical devices
5.1.3. Opportunities
5.1.3.1. Increasing mobile apps to monitor and manage diabetes
5.1.3.2. Inclination towards the home care or self-management of diabetes
5.1.4. Challenges
5.1.4.1. Lack of awareness among the people
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY DEVICE
6.1. Introduction
6.2. Diagnostic Devices
6.3. Glucose Monitoring Devices
6.4. Insulin Delivery Devices
7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TECHNIQUE
7.1. Introduction
7.2. Case-based Reasoning
7.3. Intelligent Data Analysis
8. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Bigfoot Biomedical, Inc.
12.3. Cardinal Health Inc.
12.4. Crayon Group
12.5. Diabnext
12.6. DreaMed Diabetes, Ltd.
12.7. Eyenuk, Inc.
12.8. F. Hoffmann-La Roche Ltd
12.9. HCL Technologies Limited
12.10. IBM Corporation
12.11. Karger AG
12.12. Medtronic PLC
12.13. Nasdaq Inc
12.14. Novartis AG
12.15. Novo Nordisk A/S
12.16. Sanofi SA
12.17. Virta Health Corp.
12.18. Vodafone Group PLC
12.19. Whisk
12.20. xbird GmbH
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: SCORES
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RANKING
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: MERGER & ACQUISITION
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: INVESTMENT & FUNDING
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: SCORES
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RANKING
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: MERGER & ACQUISITION
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: INVESTMENT & FUNDING
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2025
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2020 VS 2025 (%)
FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2025
FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 24. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 25. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 27. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TYPE
FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE, 2025
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2020 VS 2025 (%)
FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNIQUE, 2025
FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CASE-BASED REASONING, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTELLIGENT DATA ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 24. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 25. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 27. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. AUSTRALIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CHINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. INDIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. INDONESIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. JAPAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. MALAYSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. PHILIPPINES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. THAILAND ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. FRANCE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. GERMANY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. ITALY ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. NETHERLANDS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. QATAR ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. RUSSIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SPAIN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TYPE
